Le sale conferenze Motus Animi

mercoledì 14 marzo 2012

ADVANCES IN DERMATOPATHOLOGY: IMPROVING THE CLINICAL EFFICACY AND UP TO DATE IN MOLECULAR PATHOLOGY - GALLIPOLI, 9-10 November 2012



MOMT
V MEDITERRANEAN WORKSHOP
ADVANCES IN DERMATOPATHOLOGY:
IMPROVING THE CLINICAL EFFICACY
AND UP TO DATE IN MOLECULAR PATHOLOGY
GALLIPOLI, 9-10 November 2012

Accreditato per: Anatomo-Patologi, Patologi clinici, Chirurghi generali, Oncologi, Dermatologi, MMG, Medici Legali, Medici igienisti, Biologi, Tecnici di laboratorio biomedico, Infermieri.
ECM 11

Il corso è a pagamento, di seguito le quote d'iscrizione:
Medici e Biologi: 50 euro iva inclusa
Tecnici ed Infermieri: 30 euro iva inclusa

Membri SIAPEC e IAP: 35 euro iva inclusa


Il pagamento è da effettuare tramite bonifico a:
MOTUS ANIMI
IBAN IT 67 H 0100 5160 0300 0000 000338
BNL - AGENZIA 3703 LECCE - SWIFT BIC: BNL I I TTR
OGGETTO: MOMT GALLIPOLI + NOME E COGNOME

Inviare copia tramite mail o fax al numero 0832.165.30.00

IL CORSO SARA' TENUTO IN LINGUA ITALIANA

1st day, November 9th 2012


8,30 Registration


9,00 Welcome from Authorities
9,30 Introduction
S. A. Senatore


1st Session – Dermatopathology: never the ivory tower
Chairmen: Elio Sbano
10,00 Dermatology and dermatopathology in general practice
10,15 Clinicopathologic correlation in immunobullous diseases
Raffaele Gianotti
10,30 Psoriasis:
Paolo Broganelli
10,45 Psoriasis:
Carlo Tomasini


Coffee break


2nd Session – Melanocytic neoplasms: is H&E still the golden standard?
Chairmen: Clelia Miracco
11,30 The “dichotomic” diagnostic approach to melanocytic lesions
Harald Kittler
11,45 Advanced IHC: one stain, one diagnosis?
Claudio Clemente
12,00 “Weighting” molecular techniques
Daniela Massi
12,15 B-RAF mutations and targeted therapy
Paolo Ascierto
12,30 Discussion


Lunch


3th Session – Cutaneous lymphoproliferative disorders
Chairmen: Giovanni Quarta
15,00 Mycosis fungoides
Carlo Cota
15,15 Cutaneous B cell lymphoproliferative disorders
Marco Santucci
15,30 Rare clinico-pathologic entities
Emilio Berti
15,45 Ancillary techniques: which and when
Marco Paulli
16,00 Selecting the appropriate therapy
Nicola Pimpinelli


Coffee break


4th Session – Medicolegal concerns in dermatopathology
Chairmen:
16,30 The nightmare in a case series
16,45 How to avoid litigation
Alberto Tortorella
17,00 Quality control as a new standard of care?
Antonio Perasole
17,15 Ethical considerations and guidelines for expert reporting
B. Begliomini
17,45 Discussion


2nd day, November 10th 2012


5th Session – Up to Date in molecular pathology about other tumors
Chairmen: Elio Sbano – Giovanni Quarta
09,00 KRAS SIGNIFICANCE IN COLORECTAL CANCER
09,15 Neuroendocrine cancers of the skin
Maria Lentini
09,30 EGFR gene Mutations in non small cell lung cancer
09,45 Histopathology role in patients selection for targeted therapies


Coffee break


6th Session
Chairmen:
10,30-11,30 HER 2 in Breast and Gastric Cancer
11,30-12,30 da definire
12,30 AIDS-related Kaposi's Sarcoma: clinicopathologic approach and therapy
12,45
Oscar Nappi


13,00 Discussion


13,15 Final evaluation test